Beta thalassemia is a genetic blood disorder characterized by reduced or absent synthesis of the beta chains of hemoglobin. This leads to a variety of clinical manifestations ranging from mild anemia to severe transfusion-dependent conditions. The underlying genetic mutations affect the beta-globin gene, resulting in insufficient production of functional hemoglobin.
